Webcasts

Pandemic Preparedness: Ensuring a Robust Parenteral Packaging Supply Chain

***Live: Thursday, March 25, 2021, 10am EDT| 7am PDT| 3pm GMT | 4pm CET*** For vaccine developers, the COVID-19 pandemic has posed challenges for packaging and distributing life-saving drug products. In this webcast, learn how parenteral packaging suppliers are ready to help vaccine developers overcome these challenges and prepare for future pandemic scenarios. *** On demand available after final airing until March 25, 2022.***

Utilizing the GPEx® suite of technologies for cell line development and biomanufacturing of difficult-to-express proteins

**Tuesday, March 23, 2021, 1pm EDT | 10am PDT | 6pm GMT | 7pm CET*** Biopharmaceutical products in development continue to increase in complexity, which poses a challenge for pharmaceutical companies that are looking to improve speed and efficiency of biologic development. Join us for this webinar where we will discuss new cell line development methodologies, as well as new instrumentation, that are enabling these complex programs to be performed with shortened development timelines. *** On demand available after final airing until March 23, 2022.***

Compliance, Data Integrity and Software-based Workflow Guidance in Today’s Lab

***Live: Tuesday, March 9, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET*** Review what needs to be put in place to ensure data integrity and compliance and minimize the risk for your organization. Learn how today´s state-of-the-art laboratory balance Cubis II from Sartorius provides all the technical features needed to automate processes to ensure pharma compliance and offers digital workflow support for trusted and error-free process. ** On demand available after final airing until March 9, 2022.***

Solid Form Screening and Rational Cocrystal Design

***Live: Thursday, March 4 , 2021 at 11am EST| 8am PST| 4pm GMT| 5pm CET & Asia Pacific: Thursday, March 11, 2021 at 4pm JST | 3pm CST | 6pm AEST | 12:30pm IST*** Solid-form screening and characterization is a crucial part of drug substance development and pre-formulation. Review the underlying fundamentals of various screening methods and case studies on in-silico screening methods.*** On demand available after final airing until March 11, 2022.***

The Importance of Titrations in Pharmaceutical Analysis: From the Basics to the Modern Method

***Live: Wednesday, February 24, 2021, 1pm EST | 10am PST | 6pm GMT | 7pm CET*** Titration plays an important role in pharmaceutical analysis. Despite the recent attention given to chromatographic methods, several applications are only feasible by titration, making it a fit-for-purpose method for many analytes. For example, distinguishing between carbonate and bicarbonate or monobasic and dibasic phosphate salts can only be accomplished by titration. *** On demand available after final airing until Feb. 24, 2022.***

The Ever-Changing World of Extractables and Leachables, Part 2 A Free Virtual Conference

***Live: Wednesday, February 24, 2021 at 10am EST | 3pm GMT | 4pm CET*** Join global industry and regulatory experts as they discuss current E&L hot topics related to pharmaceuticals, biopharmaceuticals and medical devices. ***On demand available after final airing until Feb. 24, 2022***

Top Pitfalls to Avoid When Deploying a Quality and Compliance Management Solution

***Live: Tuesday, February 23, 2021, 11am EST | 8am PST | 4pm GMT | 5pm CET*** The combination of Quality 4.0 and a global pandemic created a pressing need for organizations to automate quality and compliance processes by deployment a digital quality management system. Learn about the technologies that are creating a paradigm shift within the quality and compliance space and common pitfalls to avoid when automating quality and compliance processes.*** On demand available after final airing until Feb. 23, 2022.***

Enabling Streamlined Formulation Development of Amorphous Solid Dispersion Drug Products

***Live: Thursday, January 28, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET*** Amorphous solid dispersions (ASDs) are a critical technology for bioavailability enhancement. In this webcast Lonza’s Deanna Mudie and Aaron Stewart discuss Lonza’s best practices for ASD formulation development and in vitro testing.*** On demand available after final airing until Jan. 28, 2022.***

Planning Ahead: Using Phase 1 to Anticipate Phase 2 Clinical Supply Challenges and Solutions

***Live: Tuesday, January 19, 2021, at 11am EST | 8am PST | 4pm GMT | 5pm CET ***Join this webcast to learn best practices to ensure a smooth transition from Phase 1 to Phase 2 studies, how a clinical supply provider can enable this process, as well as the role that integrated solutions can play***On demand available after final airing until Jan. 19, 2022***